LBA4Efficacy and safety of entrectinib in patients with NTRK fusion-positive tumours: Pooled analysis of STARTRK-2, STARTRK-1, and ALKA-372-001. (25th November 2018) - Demetri, G D; Paz-Ares, L; Farago, A F; Liu, S V; Chawla, S P; Tosi, D; Kim, E S; Blakely, C M; Krauss, J C; Sigal, D; Bazhenova, L; John, T; et al.